Boomerang Medical
boomerangmedical.com
Immunology & Inflammation Therapeutics
Health Care
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$20M
1 round on record
Latest round
$20M
Series B · Sep 2025 · 13 mo ago
Team
51-200
employees, estimated range
Backers
1
Arboretum Ventures
The money's age
Due for its next round
13 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 4, 2025
Raised a round Series B $20M
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | Sep 2025 | $20M | — | businesswire.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Arboretum Ventures Investors in similar startupsfunds that back the companies most like this one
backs Cullinan Therapeutics, Elpiscience
backs Ditto Bio
Similar startupsby what they do, their industry and backers
Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology.
A biotech company developing better medicines for patients with autoimmune and inflammatory diseases. Leveraging powerful insights into the…
Coultreon Biopharma is a clinical-stage biotech company developing next-generation precision medicines for immunology and autoimmune…
Valora Therapeutics is developing AbLec™ multispecific antibodies and T-Lec™ T cell engagers — antibody-engineering platforms that decoy…
About Elpiscience is a clinical-stage biopharmaceutical company dedicated to the development of innovative immunotherapies for oncology and…
Committed to developing high-impact and differentiated therapies, with a focus on building a robust autoimmune disease and cancer pipeline…
News
Good Girl Greta: What the Body Was Saying All Along
Before she ever made a film about it, Rachel Ross spent years living inside a body she had been taught not to trust while suffering from undiagnosed ulcerative colitis.
Read more
Report
Boomerang Medical: $20 Million Series B Raised To Advance Pivotal Trial in Ulcerative Colitis
Boomerang Medical, a women-led innovator in bioelectronic medicine, has announced the closing of a $20 million Series B financing round co-led by Arboretum Ventures and Hatteras Venture Partners.
Read more
Report
Business update from Business Wire
Trial evaluates neuromodulation's potential role in ulcerative colitis, the most common form of IBDMOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--September
Read more
Report
Boomerang Medical Raises $20 Million Series B to Advance Pivotal Trial of Neuromodulation in Inflammatory Bowel Disease
MOUNTAIN VIEW, Calif., September 04, 2025--Boomerang Medical raises $20M Series B for pivotal neuromodulation trial in IBD. Co-led by Arboretum Ventures & Hatteras Venture Partners.
Read more
Report
Boomerang Medical raises 20M Series B for IBD Pivotal Trial, with Arboretum and Hatteras Returning as Lead Investors
Read more
Report
How a New Clinical Trial for IBD Is Changing Frank's Life
Frank's journey with inflammatory bowel disease spans decades of pain, persistence, and hope, culminating in his participation in a groundbreaking clinical trial that could change the future of IBD treatment.
Read more
Report
NewYork-Presbyterian Enrolls First Patient in National Study of Sacral Nerve Stimulation Device for Inflammatory Bowel Disease Research Advances in Gastroenterology and GI Surgery
The IBD Center at Columbia leads enrollment in an early feasibility study of sacral nerve stimulation for the treatment of Crohn's disease and ulcerative colitis.
Read more
Report
Boomerang Medical Awarded "Promising Up-and-Comer in the Fight Against Ulcerative Colitis and Crohn's Disease" by the Crohn's & Colitis Foundation
Read more
Report
Boomerang Medical announces enrolment of first patients in IBD trial
Boomerang Medical has announced the enrolment of the first patients in its study designed for inflammatory bowel disease (IBD).
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Mountain View
United States
HQ
50-200 est. staff
2495 Hospital Drive, Mountain View, CA, 94040, US
Financials
Total raised
$20M
Latest round
Series B
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series B | 2025 | $20M | Details |